FBT
CRL icon

First Bank & Trust’s Charles River Laboratories CRL Stock Holding History

First Bank & Trust’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2
Closed – – 238
2022
Q2 		$0 Hold
2
– – ﹤0.01% 504
2022
Q1 		$1K Hold
2
– – ﹤0.01% 484
2021
Q4 		$1K Buy
+2
New +$777 ﹤0.01% 478

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

First Bank & Trust's CRL Position: Q3 2022 in Review

First Bank & Trust sold out of Charles River Laboratories (CRL) in Q3 2022, closing a stake of 2 shares.

First Bank & Trust first reported a position in CRL in Q4 2021 and held it in 3 quarters. The position peaked at $1K in Q1 2022. 583 funds tracked by Wall St. Rank hold CRL as of Q3 2022.

  • First Bank & Trust reported no remaining Charles River Laboratories position as of Q3 2022 after selling out during the quarter.
  • First Bank & Trust sold 2 Charles River Laboratories shares in Q3 2022.
  • First Bank & Trust first reported a position in Charles River Laboratories in Q4 2021 and held it in 3 quarters.
  • First Bank & Trust's Charles River Laboratories position peaked at $1K in Q1 2022.
  • 583 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2022.

Based on First Bank & Trust's 13F filing for Q3 2022, filed 28 Oct 2022.